Serum S100B protein: A useful marker in obstructive sleep apnea syndrome;Stężenie białka S100B wsurowicy jako przydatny wskaźnik wzespole obturacyjnego bezdechu podczas snu

Neurologia i Neurochirurgia Polska

Volumn 46, Issue 5, 2012, Pages 450-455

  Duru, Serap ^a   Firat, Ibrahim Hikmet ^a   Colak, Nujen ^a   Giniş, Zeynep ^a   Delibaşi, Tuncay ^a   Ardiç, Sadik ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Marker; Obstructive sleep apnea syndrome; S100B protein

Indexed keywords

BIOCHEMICAL MARKER; PROTEIN S100B;

ADULT; AGE; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING;

EID: 84869212640     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2012.31355     Document Type: Article

References (25)

1. Peker Y., Hedner J., Kraiczi H., et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-86.
2. Young T., Palta M., Dempsey J., et al. The occurrence of sleepdisordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
3. Richter D.W., Spyer K.M. Studying rhytmogenesis of breathing: comparison of in vivo and in vitro models. Trends Neurosci 2001; 24: 464-472.
4. Bloomfield S.M., McKinney J., Smith J., et al. Reliability of s100B in predicting severity of central nervous system injury. Neurocrit Care 2007; 6: 121-138.
5. Donato R. I. ntracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 60: 540-551.
6. Rothermundt M., Petres M., Prehn J.H., et al. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003; 60: 614-632.
7. Adami C., Sorci G., Blasi E., et al. S100B expression in and ef-fects on microglia. Glia 2001; 33: 131-142.
8. Jönsson H. S100B and cardiac surgery: possibilities and limi-tations. Restor Neurol Neurosci 2003; 21: 151-157.
9. Asano T., Mori T., Shimodo T., et al. Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astro-cytic overproduction of S100B. Curr Drug Targets CNS Neurol Disord 2005; 4: 127-142.
10. Wêglewski A., Ryglewicz D., Mular A., et al. Changes of protein S100B serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion. Neurol Neurochir Pol 2005; 39: 310-317.
11. Silva L.G., Mottin C.C., Souza D.O., et al. Serum S100B but not NSE levels are increased in morbidly obese individuals affected by obstructive sleep apnea-hypopnea syndrome. Obes Surg 2008; 18: 993-999.
12. Braga C.W., Martinez D., Chukchi S., et al. S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Med 2006; 7: 431-435.
13. Izci B., Ardic S., Hikmet F., et al. Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath 2008; 12: 161-168.
14. Herrmann M., Vos P., Wunderlich M.T., et al. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000; 31: 2670-2677.
15. Ettinger A., Laumark A.B., Ostroff R.M., et al. A new optical immunoassay for detection of S-100B protein in whole blood. Ann Thorac Surg 1999; 68: 2196-2201.
16. Raabe A., Kopetsch O., Woszczyk A., et al. Serum S-100B pro-tein as a molecular marker in severe traumatic brain injury. Restor Neurol Neurosci 2003; 21: 159-169.
17. Böttiger B.W., Möbes S., Glätzer R., et al. Astroglial protein S100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103: 2694-2698.
18. Mussack T., Biberthaler P., Kanz K.G., et al. S100b, sE-selectin and sP-selectin for evaluation of hypoxic brain damage in patients after cardiopulmonary resuscitation pilot study. World J Surg 2001; 25: 539-543.
19. Jordan W., Hagedohm J., Wiltfang J., et al. Biochemical markers of cerebrovascular injury in sleep apnoea syndrome. Eur Respir J 2002; 20: 158-164.
20. Sonka K., Kelemen J., Kemlink D., et al. Evening and morning plasma levels of protein S100B in patients with obstructive sleep apnea. Neuro Endocrinol Lett 2007; 28: 575-579.
21. Bertsch T, Casarin W., Kretschmar M., et al. Protein S100B: a serum marker for ischemic and infectious injury of cerebral tissue. Clin Chem Lab Med 2001; 39: 319-323.
22. Gale S.D., Hopkins R.O. Effects of hypoxia on the brain: neuro-imaging and neuropsychological findings following carbon mono-xide poisoning and obstructive sleep apnea. J Int Neuropsychol Soc 2004; 10: 60-71.
23. Hu J., Ferreira A., Van Eldik L.J. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 1997; 69: 2294-2301.
24. Dursunoǧlu N., Dursunoǧlu D. Obstructive sleep apnea syn-drome, endothelial dysfunction and coronary atherosclerosis. Tuber Toraks 2005; 53: 299-306.
25. Kleindienst A., Ross Bullock M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma 2006; 23: 1185-1200.